VE-Su-Sper/DSPE-PEG2000/siSurvivin nanocomplex significantly inhibited the tumor growth in HepG2-tumor-bearing mice, and the tumor volume and weight were about 4-fold smaller than other groups, and survivin expression was significantly reduced in tumor tissues [114]. This evidence concerns the gene BIRC5 and neoplasm.